These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32391993)

  • 21. [Initial pharmacological treatment of the patient with heart failure with reduced systolic function: is the order of the initial and subsequent doses important?].
    Formiga F; Nuñez J
    Rev Esp Geriatr Gerontol; 2018; 53(4):183-184. PubMed ID: 29887284
    [No Abstract]   [Full Text] [Related]  

  • 22. Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study.
    Majumdar SR; McAlister FA; Cree M; Chang WC; Packer M; Armstrong PW;
    Clin Ther; 2004 May; 26(5):694-703. PubMed ID: 15220013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF.
    Heywood JT; Fonarow GC; Yancy CW; Albert NM; Curtis AB; Gheorghiade M; Inge PJ; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
    Circ Heart Fail; 2010 Sep; 3(5):596-605. PubMed ID: 20634483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physicians' adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey.
    Komajda M; Anker SD; Cowie MR; Filippatos GS; Mengelle B; Ponikowski P; Tavazzi L;
    Eur J Heart Fail; 2016 May; 18(5):514-22. PubMed ID: 27095461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry.
    Maggioni AP; Anker SD; Dahlström U; Filippatos G; Ponikowski P; Zannad F; Amir O; Chioncel O; Leiro MC; Drozdz J; Erglis A; Fazlibegovic E; Fonseca C; Fruhwald F; Gatzov P; Goncalvesova E; Hassanein M; Hradec J; Kavoliuniene A; Lainscak M; Logeart D; Merkely B; Metra M; Persson H; Seferovic P; Temizhan A; Tousoulis D; Tavazzi L;
    Eur J Heart Fail; 2013 Oct; 15(10):1173-84. PubMed ID: 23978433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin-converting enzyme inhibitors or beta-blockers in heart failure: does it matter who goes first?
    Fang JC
    Circulation; 2005 Oct; 112(16):2380-2. PubMed ID: 16230494
    [No Abstract]   [Full Text] [Related]  

  • 27. Beta-blockers, calcium channel blockers, angiotensin converting enzyme inhibitors and angiotensin receptor blockers: should they be stopped or not before ambulatory anaesthesia?
    Smith I; Jackson I
    Curr Opin Anaesthesiol; 2010 Dec; 23(6):687-90. PubMed ID: 20805745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical benefit of eplerenone in patients with mild symptoms of systolic heart failure already receiving optimal best practice background drug therapy: analysis of the EMPHASIS-HF study.
    Krum H; Shi H; Pitt B; McMurray J; Swedberg K; van Veldhuisen DJ; Vincent J; Pocock S; Zannad F;
    Circ Heart Fail; 2013 Jul; 6(4):711-8. PubMed ID: 23625945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk-treatment mismatch in the pharmacotherapy of heart failure.
    Lee DS; Tu JV; Juurlink DN; Alter DA; Ko DT; Austin PC; Chong A; Stukel TA; Levy D; Laupacis A
    JAMA; 2005 Sep; 294(10):1240-7. PubMed ID: 16160132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of a Pharmacist-Managed Heart Failure Medication Titration Assistance Clinic.
    Bhat S; Kansal M; Kondos GT; Groo V
    Ann Pharmacother; 2018 Aug; 52(8):724-732. PubMed ID: 29463107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gap between guidelines and clinical practice in heart failure with reduced ejection fraction: Results from TSOC-HFrEF registry.
    Chang HY; Wang CC; Wei J; Chang CY; Chuang YC; Huang CL; Chong E; Lin JL; Mar GY; Chan KC; Kuo JY; Wang JH; Chen ZC; Tseng WK; Cherng WJ; Yin WH
    J Chin Med Assoc; 2017 Dec; 80(12):750-757. PubMed ID: 29033112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implementation of a pharmacist-managed heart failure medication titration clinic.
    Martinez AS; Saef J; Paszczuk A; Bhatt-Chugani H
    Am J Health Syst Pharm; 2013 Jun; 70(12):1070-6. PubMed ID: 23719886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of oral chronic pharmacotherapy in patients hospitalized for acute decompensated heart failure.
    Piepoli M; Binno S; Villani GQ; Cabassi A
    Int J Cardiol; 2014 Sep; 176(2):321-6. PubMed ID: 25129309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapy with ACE inhibitors and ARBs in heart failure.
    Cayley WE
    Am Fam Physician; 2004 Jul; 70(2):261. PubMed ID: 15291087
    [No Abstract]   [Full Text] [Related]  

  • 35. Critical evaluation of the optimal medical therapy in the cardiac resynchronization therapy candidates--single centre experience.
    Vondráková D; Málek F; Dvorák J; Sedivá L; Kupec J; Petrů J; Táborský M; Neuzil P
    Vnitr Lek; 2011 Oct; 57(10):799-802. PubMed ID: 22097686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-blocker treatment before angiotensin-converting enzyme inhibitor therapy in newly diagnosed heart failure.
    Willenheimer R; van Veldhuisen DJ; Ponikowski P; Lechat P;
    J Am Coll Cardiol; 2005 Jul; 46(1):182. PubMed ID: 15992659
    [No Abstract]   [Full Text] [Related]  

  • 37. [Contemporary approaches to diagnosis and management of chronic heart failure (summary of the American College of Cardiology/American Heart Association Guidelines)].
    Sidorenko BA; Preobrazhensky DV; Batyraliev TA; Marenitch AV; Romanova NE
    Kardiologiia; 2002; 42(6):65-78. PubMed ID: 12494135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does the target dose of neurohormonal blockade matter for outcome in Systolic heart failure in octogenarians?
    Barywani SB; Ergatoudes C; Schaufelberger M; Petzold M; Fu ML
    Int J Cardiol; 2015; 187():666-72. PubMed ID: 25880407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in chronic heart failure.
    Regier LD; Jensen B
    Ann Intern Med; 2005 Mar; 142(5):388; author reply 388-9. PubMed ID: 15738461
    [No Abstract]   [Full Text] [Related]  

  • 40. Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in chronic heart failure.
    Peeters MJ; Tsikouris JP
    Ann Intern Med; 2005 Mar; 142(5):388; author reply 388-9. PubMed ID: 15738462
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.